This review aims to assess the benefits and harms of fenoldopam for the prevention or treatment of AKI in children and adults.
This is a protocol.
Fenoldopam for preventing and treating acute kidney injury
You may also be interested in:
- Dopamine versus no treatment to prevent renal dysfunction in indomethacin-treated preterm newborn infants
- Atrial natriuretic peptide for preventing and treating acute kidney injury
- Polyclonal and monoclonal antibodies for treating acute rejection episodes in kidney transplant recipients
- Antidepressants for treating depression in adults with end-stage kidney disease treated with dialysis
- Dopamine agonists for preventing future miscarriage in women with high prolactin levels and a history of recurrent miscarriage
Health topics: